Drug Shortage Report for CEFUROXIME FOR INJECTION, USP
Report ID | 122228 |
Drug Identification Number | 02422298 |
Brand name | CEFUROXIME FOR INJECTION, USP |
Common or Proper name | CEFUROXIME FOR INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | CEFUROXIME |
Strength(s) | 750MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25 VIALS |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-10-30 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-10-31 |
Company comments | BUSINESS REASONS. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-10-31 | English | Compare |
v2 | 2020-08-13 | French | Compare |
v1 | 2020-08-13 | English | Compare |
Showing 1 to 3 of 3